Distinguished cancer researchers Garrett M. Brodeur, MD, Susan Domchek, MD, Stephan Grupp, MD, PhD, and Robert Vonderheide, MD, DPhil, from the Perelman School of Medicine at the University of Pennsylvania and Penn Medicine’s Abramson Cancer Center have been elected to the 2025 class of Fellows of the American Association for Cancer Research (AACR) Academy.
A combination of mRNA and a new lipid nanoparticle could help heal damaged lungs, according to new research from the Perelman School of Medicine at the University of Pennsylvania. Viruses, physical trauma, or other problems can have serious impact on lungs, and when the damage is in the lower regions, traditional treatments, like inhaled medication, might not work.
A Penn Medicine pilot study shows it’s possible to use digital technology to safely reduce the amount of time some patients with cancer spend receiving care.
Penn Medicine announced a transformative gift from Catherine and Anthony Clifton to usher in a new era of innovation in clinical care, research, and education. edge healthcare for all. In recognition of the gift, the Pavilion at the Hospital of the University of Pennsylvania will be renamed The Clifton Center for Medical Breakthroughs.
PHILADELPHIA – Over 1000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study, published in , from researchers at the Perelman School of Medicine at the University of Pennsylvania. By creating the most complete and detailed genetic “map” of kidney function to date, the researchers have paved the way for more precise diagnosing of kidney disease, strategies to prevent it, and ways to treat it.
More than 90% of the adult population in the U.S. is or has been infected with Epstein Barr virus (EBV). EBV is a highly contagious member of the herpes virus family, best known for causing infectious mononucleosis ("mono") and for its association with several cancers and autoimmune diseases. Kidney transplant patients who’ve never been exposed to EBV but receive organs from a donor who carried the virus may develop a life-threatening post-transplant complication called lymphoproliferative disorder (PTLD), according to a new study from the Perelman School of Medicine at the University of Pennsylvania. An estimated 4 to 5 percent of adult kidney transplants – as many as 1200 patients per year – could be at risk of the condition, in which the body’s immune system gets confused and immune cells can grow out of control and act like cancer. The findings were recently published in Annals of Internal Medicine.
Set to enter hospice care, a patient with idiopathic multicentric Castleman’s disease is now in remission after treatment with a medication identified by an AI-guided analysis
Susan M. Domchek, MD, FASCO, has been recognized by the American Society of Clinical Oncology (ASCO) with one of the society’s highest honors, as the 2025 recipient of the ASCO-American Cancer Society Cancer Prevention Award.
Standardizing an assessment process currently used by doctors during care discussions with veterans at risk for suicide in other context could shed more light on the risks related to firearms and opioids.
Pari V. Pandharipande, MD, MPH, FACR, a nationally renowned physician-scientist at The Ohio State University (OSU) College of Medicine and Wexner Medical Center, has been named Chair of the department of Radiology at Penn Medicine, effective June 1, 2025.
A new twist on a decades-old anticancer strategy has shown powerful effects against multiple cancer types in a preclinical study from researchers in the Perelman School of Medicine at the University of Pennsylvania.
A new AI tool can search through data and histology images for exponentially more precise information on cancer treatment effectiveness than what can be gleaned from CT or MRI scans
A new machine learning technique could help inform clinical decision-making across hospital systems to address the challenges of long COVID-19 care.
Researchers at the Perelman School of Medicine at the University of Pennsylvania have set out to identify, quantify, and classify the many viruses living in our bodies so that future research can uncover how they affect human health.
Opioid misuse and specifically opioid use disorder (OUD), continues to represent a significant U.S. public health threat, with more than 6 million Americans aged 12 and older meeting the criteria for OUD in 2022. Efforts to ease the crisis have included the development of genetic testing to identify individuals most at risk for OUD.
The foundation of health care is strengthened by those who deliver that care, particularly by those who supplement their work through voluntary action. 37 Penn Medicine staff and medical students used Penn Medicine CAREs grants to serve their communities and beyond, from distributing warm clothes and food to helping young people who have been impacted by HIV/AIDS.
Two new companies will each receive a $250,000 investment from the Penn Medicine-Wharton Fund for Health: Cayaba Care, a maternal health start-up, and On the Goga, a workplace well-being company.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right